Advertisement

Topics

Harbor BioSciences, Inc. Company Profile

02:47 EST 18th November 2018 | BioPortfolio

Harbor BioSciences is a development-stage company with two product candidates in clinical trials: Apoptone (HE3235), in the cohort expansion portion of a Phase I/IIa trial of patients with late-stage prostate cancer, and Triolex®, in a Phase IIa trial in obese type 2 diabetes mellitus patients. Apoptone and Triolex represent the lead candidates from Harbor BioSciences' small molecule platform based on metabolites or synthetic analogs of endogenous steroid hormones. For more information on Harbor BioSciences please visit www.harborbiosciences.com.


News Articles [752 Associated News Articles listed on BioPortfolio]

Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion

Illumina, Inc. and Pacific Biosciences announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction....

Strategic partnership forms between Taconic Biosciences and Cyagen Biosciences

A strategic partnership has been formed between Taconic Biosciences and Cyagen Biosciences — both global companies that generate custom genetically engineered rodent models and associated services.

What would it take to turn Boston harbor into tea? (video)

(American Chemical Society) On December 16, 1773, the Boston tea party protestors threw more than 340 chests full of tea -- the equivalent of about 18 and a half million teabags -- into the harbor. Wo...

African Women for Biosciences Platform Launched

Women in biosciences remain grossly under represented in leadership and decision-making levels, limiting contribution of scientific research to national development. A new platform - the African Women...

Illumina To Acquire Pacific Biosciences At $8.00/shr

SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN) and Pacific Biosciences (PACB) announced an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in a...

Kaskela Law LLC: IMPORTANT SHAREHOLDER DEADLINE ALERT: Solid Biosciences, Inc. - SLDB

RADNOR, PA / ACCESSWIRE / May 23, 2018 / Kaskela Law LLC reminds Solid Biosciences, Inc. (NASDAQ: SLDB) ("Solid Biosciences" or the "Company") investors that a class action complaint has been filed...

Kuros Biosciences Ltd.: Kuros Biosciences appoints Strategic Advisory Board

Kuros Biosciences appoints Strategic Advisory Board Schlieren (Zurich), Switzerland, September 25, 2018 - Kuros Biosciences (SIX: KURN) today announced the formation of its Strategic Advisory Boar...

Kuros Biosciences Ltd.: Kuros Biosciences appoints Pascal Longlade as Chief Medical Officer

Kuros Biosciences appoints Pascal Longlade as Chief Medical Officer Schlieren (Zurich), Switzerland, August 23, 2018 Kuros Biosciences AG (SIX: KURN) announced today the appointment of Pascal Long...

PubMed Articles [168 Associated PubMed Articles listed on BioPortfolio]

Influence of ship emissions on NO, SO, O and PM concentrations in a North-Sea harbor in France.

The influence of in-port ship emissions on gases and PM concentrations has been estimated in the port city of Calais, northern France, one of the busiest harbor in Europe, with numerous rotations of f...

Characteristics of PM from ship emissions and their impacts on the ambient air: A case study in Yangshan Harbor, Shanghai.

The rapid development of ports in China over the last two decades has had inevitable consequences on the ambient air quality in coastal areas and harbors. For mitigation strategies and monitoring aims...

Contents list.

Front cover.

Back cover.

Clinical Trials [67 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas

This is a study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and anti-tumor activity of DS-1001b in patients with gliomas that harbor IDH1-R132 mutation...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Companies [412 Associated Companies listed on BioPortfolio]

Harbor BioSciences, Inc.

Harbor BioSciences is a development-stage company with two product candidates in clinical trials: Apoptone (HE3235), in the cohort expansion portion of a Phase I/IIa trial of patients with late-stage ...

Merck Biosciences UK

Merck Biosciences UK respects your privacy. Through its brands of Calbiochem, Novagen, Novabiochem and Clinalfa and its affiliation with Merck KGaA, Darmstadt, Germany, one of the largest worldwide ma...

BioSupplyNet

BioSupplyNet is owned and operated by Cold Spring Harbor Laboratory Press which is the largest of the five education divisions of Cold Spring Harbor Laboratory, New York. The Press assists the advance...

Digital Harbor Inc.

Digital Harbor, a leader in Enterprise Innovation, carries over 20 years of expertise in transforming enterprises to make quicker and smarter business decisions through tec...

Safe Harbor

Safe Harbor(TM) certification - the first venture of Micro Analytical Systems, Inc. (MASI) - is the only process for fast, large-scale mercury testing of seafood, enabling processing plants and distri...

More Information about "Harbor BioSciences, Inc." on BioPortfolio

We have published hundreds of Harbor BioSciences, Inc. news stories on BioPortfolio along with dozens of Harbor BioSciences, Inc. Clinical Trials and PubMed Articles about Harbor BioSciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Harbor BioSciences, Inc. Companies in our database. You can also find out about relevant Harbor BioSciences, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...


Corporate Database Quicklinks



Searches Linking to this Company Record